Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

CSL Limited to Construct New Biotech Facility

By Pharmaceutical Processing | July 16, 2010

CSL Limited has announced a major biotechnology project at CSL’s manufacturing site in Broadmeadows, Australia.

The centrepiece of the project will be the creation of Victoria’s first large scale biotechnology facility for the late stage development of new therapies for cancer, bleeding disorders, inflammation and infection.

“Our world-class R&D portfolio contains promising life-saving therapies for a range of serious human diseases. This new facility will enable CSL to develop innovative products for clinical trials and future patient use,” said CSL’s CEO, Dr Brian McNamee.

CSL’s Broadmeadows site currently houses state-of-the-art manufacturing facilities that produce a range of highly specialised medicines. CSL’s investment will include enhancements to the site to support the integration of the new biotech facility and to ensure it has the appropriate infrastructure to cater for expanded activities into the future.

The project will represent a total investment of $235M over 4-5 years and will result in 320 jobs during construction. Following completion, the investment will create over 330 new highly-skilled positions.

“CSL is proud to be investing in a project that will not only generate significant employment opportunities, but will also have enormous spill-over potential for our biotechnology sector and medical research community” said Dr McNamee.

“This significant project enables us to build on our existing capabilities and research collaborations, further develop the nation’s biotechnology skills and work towards our important goal of improving the lives of people with life-threatening disease.”

Related Articles Read More >

Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040
Fujifilm Diosynth Technologies
Fujifilm to spend $1.6B to bolster cell culture manufacturing services
Wyzo
Wyzo high-speed pick-and-place sidebot wins design awards
Purdue University
Purdue University launches institute for advanced manufacturing of pharmaceuticals

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards